These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 951048)

  • 21. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
    Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
    Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of endogenous GH secretion during hyperthermic bath on glucose metabolism and insulin release in man.
    Jurcovicová J; Vigas M; Palát M; Jezová D; Klimes I
    Endocrinol Exp; 1980 Sep; 14(3):221-6. PubMed ID: 7002532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disturbances of carbohydrate regulation in hepatic lesions].
    Magnenat P
    Helv Med Acta; 1970 Dec; 35(5):354-62. PubMed ID: 5501843
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone in blood plasma of patients with liver cirrhosis.
    Kasperska-Czyzykowa T; Rogala H
    Acta Med Pol; 1978; 19(4):485-92. PubMed ID: 752250
    [No Abstract]   [Full Text] [Related]  

  • 26. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered control of growth hormone secretion in patients with cirrhosis of the liver.
    Muggeo M; Tiengo A; Fedele D; Crepaldi G
    Arch Intern Med; 1979 Oct; 139(10):1157-60. PubMed ID: 485748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis.
    Shmueli E; Stewart M; Alberti KG; Record CO
    Hepatology; 1994 Feb; 19(2):322-8. PubMed ID: 7904978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions.
    Collins JR; Lacy WW; Stiel JN; Crofford OB
    Arch Intern Med; 1970 Oct; 126(4):608-14. PubMed ID: 5506964
    [No Abstract]   [Full Text] [Related]  

  • 31. Hormonal and metabolic studies in pheochromocytoma.
    Calandra RS; Antar MA; Plautz M; Little JA; Martin JM; Johnson GE
    Can Med Assoc J; 1970 Jun; 102(13):1369-72. PubMed ID: 5422431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of atropine on the course of oral glucose tolerance test in patients with liver cirrhosis (author's transl)].
    Brodanová M; Andĕl M; Brodan V; Kuhn E; Vondra K
    Cas Lek Cesk; 1978 Jul; 117(29-30):898-900. PubMed ID: 688315
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucose, FFA, IRI and GH response to I.V. glibenclamide.
    Rastogi GK; Dash RJ; Sinha MK
    Horm Metab Res; 1973 Jul; 5(4):303. PubMed ID: 4199903
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on glucose, amino acid and protein metabolism in patients with liver cirrhosis in relation to plasma levels of human growth hormone (author's transl)].
    Ogura C
    Hokkaido Igaku Zasshi; 1975 Sep; 50(5):489-506. PubMed ID: 815150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of the carbohydrate intolerance of cirrhosis.
    Proietto J; Alford FP; Dudley FJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1030-6. PubMed ID: 6999005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The altered plasma amino acid pattern is responsible for the paradoxical growth hormone response to the oral glucose tolerance test in liver cirrhosis.
    Martina V; Tagliabue M; Bruno GA; Bonetti G; Brancaleoni V; Meineri I; Saracco G; Zumpano E; Manieri C; Camanni F
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):175-80. PubMed ID: 9579229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular alterations and GH secretion in latent chemical diabetes].
    Sgambato S; Carbone L; Bisesti V; Passariello N; Tesauro P; Varano R
    Boll Soc Ital Biol Sper; 1979 Feb; 55(3):279-85. PubMed ID: 399851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver cirrhosis and diabetes mellitus].
    Verlohren HJ; Lohmann D
    Z Gesamte Inn Med; 1977 Jan; 32(1):34-7. PubMed ID: 857443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in blood sugar, IRI, growth hormone and plasma glucagon induced by somatostatin in subjects with liver cirrhosis].
    Gragnoli G; Tanganelli I; Martinelli G; Genazzani AR; Brandi L; Kristodhullu A
    Boll Soc Ital Biol Sper; 1977 Oct; 53(19):1634-40. PubMed ID: 607967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.